Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

Research has demonstrated the negative consequences of excessive added sugar intake, yet the government continues to support ...

This means one in 10 new type 2 diabetes and one in 30 new cardiovascular cases were due to sugar-sweetened beverages, ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval ...

A front-of-package food label would be a great educational tool. The Trump administration should keep it.